Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PYXS stock hub

Pyxis Oncology, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PYXSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

172.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PYXS

In the news

Latest news · PYXS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-91.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-48

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PYXS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001782223
Company name	Pyxis Oncology, Inc.
Country	United States
Country code	US
Cusip	747324101
Employees	56
Employees Change	12%
Employees Change Percent	27.27
Enterprise value	$124M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-10-01
Isin	US7473241013
Last refreshed	2026-05-10
Market cap	$172.2M
Market cap category	Micro-Cap
Price	$2.74
Price currency	USD
Rev Per Employee	247,464.29x
Sector	Healthcare
Sic	2834
Symbol	PYXS
Website	https://www.pyxisoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-46.25%
EV/Sales	8.95x
FCF yield	-36.89%
P/B ratio	3.22x
P/S ratio	12.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	82.77%
Gross Profit	$11.5M
Gross Profit Growth	-26.81%
Net Income	$-79.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-564.55%
Profit Per Employee	$-1.4M
ROA	-41.14
Roa5y	-30.69
ROCE	-116.3
ROE	-91.43
Roe5y	-63.93
ROIC	-48.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	156.24%
Cagr3y	-1.76%
EPS Growth Quarters	1
EPS Growth Years	5
Revenue Growth	-14.17x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.11
Assets	$91.5M
Cash	$66.9M
Current Assets	$72.1M
Current Liabilities	$21.1M
Debt	$18.7M
Debt Equity	$0.35
Equity	$53.4M
Liabilities	$38.1M
Long Term Assets	$19.4M
Long Term Liabilities	$17M
Net Cash	$48.2M
Net Cash By Market Cap	$27.99
Net Cash Growth	-54.85%
Net Debt Equity	$-0.9
Tangible Book Value	$53.4M
Tangible Book Value Per Share	$0.85
WACC	10.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.41
Net Working Capital	$-14.2M
Quick ratio	3.2
Working Capital	$51M
Working Capital Turnover	$0.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.33%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	156.08%
200-day SMA	2.19
3Y total return	-5.19%
50-day SMA	1.62
50-day SMA vs 200-day SMA	50under200
All Time High	19
All Time High Change	-85.58%
All Time High Date	2021-10-08
All Time Low	0.83
All Time Low Change	228.85%
All Time Low Date	2025-04-07
ATR	0.2
Beta	1.43
Beta1y	1.08
Beta2y	1.23
Ch YTD	138.3
High	2.77
High52	5.55
High52 Date	2025-11-26
High52ch	-50.63%
Low	2.24
Low52	0.97
Low52 Date	2025-08-11
Low52ch	182.47%
Ma50ch	68.72%
Premarket Change Percent	-0.44
Premarket Price	$2.25
Premarket Volume	2,586
Price vs 200-day SMA	24.89%
RSI	79.93
RSI Monthly	50.4
RSI Weekly	59.88
Sharpe ratio	1.4x
Sortino ratio	2.18
Total Return	-6.33%
Tr YTD	138.3
Tr1m	87.67%
Tr1w	59.3%
Tr3m	81.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	1
Analyst Price Target Top	$7
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.35
Operating Income	$-81.8M
Operating margin	-590.6
Price target	$6.83
Price Target Change	$149
Price Target Change Top	$155

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,395,535%
Float Percent	64.29%
Shares Insiders	5.96%
Shares Institutions	22.63%
Shares Out	62,831,246
Shares Qo Q	0.76%
Shares Yo Y	6.33%
Short Float	5.62%
Short Ratio	5.92
Short Shares	3.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-75.3M
Average Volume	554,799.05x
Bv Per Share	0.85
CAPEX	$-9,000
Ch1m	87.67
Ch1w	59.3
Ch1y	156.1
Ch3m	81.46
Ch3y	-5.19
Ch6m	-29.92
Change	21.24%
Change From Open	20.7
Close	2.26
Days Gap	0.44
Depreciation Amortization	4,511,000
Dollar Volume	5,470,640.2
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$-81.8M
EBITDA	$-77.3M
EPS	$-1.28
F Score	2
FCF	$-63.5M
FCF EV Yield	-51.23x
FCF Per Share	$-1.01
Financing CF	594,000
Fiscal Year End	December
Founded	2,018
Income Tax	$1.4M
Investing CF	58,857,000
Ipr	-82.88
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-23
Ma150	2.41
Ma150ch	13.93%
Ma20	1.84
Ma20ch	48.83%
Net CF	-4,051,000
Next Earnings Date	2026-05-22
Open	2.27
Optionable	Yes
Position In Range	95.24
Post Close	2.74
Postmarket Change Percent	-10.58
Postmarket Price	$2.45
Ppne	19,415,000
Pre Close	2.26
Price Date	2026-05-08
Ptbv Ratio	3.22
Relative Volume	3.6x
Revenue	13,858,000x
SBC By Revenue	85.16x
Share Based Comp	11,801,000
Tax By Revenue	10x
Tr6m	-29.92%
Us State	Massachusetts
Volume	1,996,584
Z Score	-7.09

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PYXS pay a dividend?

Capital-return profile for this ticker.

Performance

PYXS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PYXS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.6%

Float: +64.3% of shares outstanding

Insider ownership

+6.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PYXS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

79.9

Above 70: short-term overbought

Price vs 200-day MA

+24.9%

50/200-day relationship not available

Beta (5Y)

1.43

More volatile than the market

Sharpe ratio

1.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PYXS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PYXS stock rating?

Pyxis Oncology, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PYXS analysis?

The full report lives at /stocks/PYXS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PYXS?

The latest report frames PYXS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PYXS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.